Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut R Maecke

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2008
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumoursStephan Good, Martin A Walter, Beatrice Waser, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Bioconjugate Chemistry|May 15, 2015
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptorPetra Kolenc Peitl, MariaLuisa Tamma, Marko Kroselj, et al.
Molecular Pharmaceutics|April 14, 2012
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugatesMelpomeni Fani, Maria-Luisa Tamma, Guillaume P Nicolas, et al.
Plos One|October 2, 2012
Evolution of bombesin conjugates for targeted PET imaging of tumorsHanwen Zhang, Keelara Abiraj, Daniel L J Thorek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 AntibodySvetlana N Rylova, Luigi Del Pozzo, Cathrin Klingeberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2012
Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modificationsMelpomeni Fani, Friederike Braun, Beatrice Waser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2012
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotideAriane Boubaker, John O Prior, Jean-Pierre Willi, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2008
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumoursStephan Good, Martin A Walter, Beatrice Waser, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Bioconjugate Chemistry|May 15, 2015
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptorPetra Kolenc Peitl, MariaLuisa Tamma, Marko Kroselj, et al.
Molecular Pharmaceutics|April 14, 2012
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugatesMelpomeni Fani, Maria-Luisa Tamma, Guillaume P Nicolas, et al.
Plos One|October 2, 2012
Evolution of bombesin conjugates for targeted PET imaging of tumorsHanwen Zhang, Keelara Abiraj, Daniel L J Thorek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 AntibodySvetlana N Rylova, Luigi Del Pozzo, Cathrin Klingeberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2012
Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modificationsMelpomeni Fani, Friederike Braun, Beatrice Waser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2012
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotideAriane Boubaker, John O Prior, Jean-Pierre Willi, et al.
Pageof 9